treatment guidelines

Research Reports

Can We Fill in the Gaps? Authoring Custom Oncology Pathways vs Surfacing NCCN Preferred Recommendations Alone

06/05/2023

Rebecca Maniago, PharmD, BCOP

Marcello Ricottone

Gregory S. Calip, PharmD, MPH, PhD

Taylor Dias-Foundas

James Hamrick, MD, MPH

Rebecca Maniago, PharmD, and colleagues compare the overall availability of NCCN Preferred recommendations to custom preferred pathways and assess provider concordance with the preferred suggestions, particularly those encountered in the...

Rebecca Maniago, PharmD, and...

06/05/2023

Journal of Clinical Pathways

News

Standardized Treatment Guidelines Reduce Induction Mortality in APL

12/17/2020

Journal of Clinical Pathways

From the Field

Developing Pathway to Cure: A Multimodal Clinical Pathway Platform to Support Timely and Appropriate Care of Women Under 50 Diagnosed With Breast Cancer

09/18/2020

Robin M Lally, PhD, MS, RN, AOCN, FAAN1,2

Roksana Zak, PhD1

Ryan Ramaekers, MD3

Allison F Coates, BS, BSN, RN1

Elizabeth Reed, MD2

Abstract: Pathway to Cure is a multimodal eHealth platform for oncology care providers and patients developed by a multidisciplinary team at the University of Nebraska Medical Center’s Fred & Pamela Buffett...

...

09/18/2020

Journal of Clinical Pathways

Guideline Updates

NCCN B-Cell Lymphomas Guideline Features Therapy Updates in Follicular Lymphoma, DLBCL

07/13/2020

The National Comprehensive Cancer Network (NCCN) released an update to its guideline for B-cell lymphomas. In the section for follicular lymphoma with histologic transformation to diffuse large B-cell lymphoma...

The...

07/13/2020

Journal of Clinical Pathways

Guideline Updates

AUA, ASTRO, and SUO Release Consensus Guideline on Advanced Prostate Cancer

06/30/2020

The American Urological Association (AUA), American Society for Radiation Oncology (ASTRO), and Society of Urologic Oncology (SUO) released a new clinical practice guideline for the diagnosis and treatment of...

The...

06/30/2020

Journal of Clinical Pathways

Guideline Updates

ASCO Special Report Offers Guidance on Resuming Cancer Care During COVID-19

05/20/2020

The American Society of Clinical Oncology (ASCO) published a special report to provide guidance to oncology practices on resuming cancer care during the COVID-19 pandemic. While communities across the US are...

The...

05/20/2020

Journal of Clinical Pathways

Practical Research

Evaluation of the Management of UTIs in Cognitively Impaired Older Women in LTC

03/10/2020

Morgan C Johnson, DNP, FNP-BC

Ruth Kleinpell, PhD, RN, FAAN, FAANP, FCCM

Todd Hulgan, MD, MPH

Carol Callaway-Lane, DNP, ACNP-BC

Joseph M Price, PhD, MBA, PMP

A retrospective review of 152 urinalyses was conducted in one long-term care facility to assess the management of urinary tract infections.

A retrospective review of 152...

03/10/2020

Annals of Long-Term Care

Research Reports

KRAS/RAS Testing Is Associated With Reduced Risk of Treatment Discontinuation in Patients With Metastatic Colorectal Cancer

08/22/2018

Alexandra Christodoulopoulou, MSc

Bruce A Bach, MD, PhD

Andrew J Klink, PhD, MPH

Guy Hechmati, MD, MSc

Urvi Mujumdar, MPH

Bruce A Feinberg, DO

Marwan Fakih, MD

Abstract: Current clinical guidelines recommend that all patients with metastatic colorectal cancer (mCRC) have tumor tissue genotyped for RAS mutations. This study aimed to evaluate patient characteristics and...

...

08/22/2018

Journal of Clinical Pathways

Feature

Multidisciplinary Management of Multiple Myeloma in Older Adults

08/17/2017

Nader Tavakoli, MD, CMD, FAAFP

Sidrah Khan, MD

Shelby Knowles, MD

Richard Stefanacci, DO, MGH, MBA, AGSF, CMD

Abstract: Multiple myeloma (MM) is a progressive and fatal disease, primarily affecting men aged 66 years or older. Because MM is primarily a disease of the elderly, it is incumbent on geriatricians and primary care...

...

08/17/2017

Journal of Clinical Pathways

Research in Review

Pancreatic Cancer Guidelines Do Not Cover Some Targetable Mutations

08/11/2017

JCP Editors

Germline mutations in pancreatic cancer susceptibility genes are often identified in patients with pancreatic cancer without a known family history of cancer, according to a recent study. ----- Related...

...

08/11/2017

Journal of Clinical Pathways